New York, Sept. 24, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Respiratory Disease Testing Industry" - https://www.reportlinker.com/p05959891/?utm_source=GNW
3 Billion by 2027, growing at a CAGR of 2.2% over the analysis period 2020-2027. Imaging, one of the segments analyzed in the report, is projected to record a 2.4% CAGR and reach US$2.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Spirometry segment is readjusted to a revised 2.8% CAGR for the next 7-year period.
The U.S. Market is Estimated at $756.9 Million, While China is Forecast to Grow at 4.3% CAGR
The Respiratory Disease Testing market in the U.S. is estimated at US$756.9 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$643.6 Million by the year 2027 trailing a CAGR of 4.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 0.4% and 1.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 1% CAGR.
Blood Gas Segment to Record 1.6% CAGR
In the global Blood Gas segment, USA, Canada, Japan, China and Europe will drive the 1.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$167.3 Million in the year 2020 will reach a projected size of US$183 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$441.7 Million by the year 2027, while Latin America will expand at a 2% CAGR through the analysis period. We bring years of research experience to this 9th edition of our report. The 283-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Competitors identified in this market include, among others,
Read the full report: https://www.reportlinker.com/p05959891/?utm_source=GNW
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Global Competitor Market Shares
Respiratory Disease Testing Competitor Market Share Scenario
Worldwide (in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: Respiratory Disease Testing Global Market Estimates
and Forecasts in US$ Million by Region/Country: 2020-2027
Table 2: Respiratory Disease Testing Global Retrospective
Market Scenario in US$ Million by Region/Country: 2012-2019
Table 3: Respiratory Disease Testing Market Share Shift across
Key Geographies Worldwide: 2012 VS 2020 VS 2027
Table 4: Imaging (Test Type) World Market by Region/Country in
US$ Million: 2020 to 2027
Table 5: Imaging (Test Type) Historic Market Analysis by
Region/Country in US$ Million: 2012 to 2019
Table 6: Imaging (Test Type) Market Share Breakdown of
Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027
Table 7: Spirometry (Test Type) Potential Growth Markets
Worldwide in US$ Million: 2020 to 2027
Table 8: Spirometry (Test Type) Historic Market Perspective by
Region/Country in US$ Million: 2012 to 2019
Table 9: Spirometry (Test Type) Market Sales Breakdown by
Region/Country in Percentage: 2012 VS 2020 VS 2027
Table 10: Blood Gas (Test Type) Geographic Market Spread
Worldwide in US$ Million: 2020 to 2027
Table 11: Blood Gas (Test Type) Region Wise Breakdown of Global
Historic Demand in US$ Million: 2012 to 2019
Table 12: Blood Gas (Test Type) Market Share Distribution in
Percentage by Region/Country: 2012 VS 2020 VS 2027
Table 13: Other Test Types (Test Type) World Market Estimates
and Forecasts by Region/Country in US$ Million: 2020 to 2027
Table 14: Other Test Types (Test Type) Market Historic Review
by Region/Country in US$ Million: 2012 to 2019
Table 15: Other Test Types (Test Type) Market Share Breakdown
by Region/Country: 2012 VS 2020 VS 2027
Table 16: Hospitals (End-Use) Worldwide Latent Demand Forecasts
in US$ Million by Region/Country: 2020-2027
Table 17: Hospitals (End-Use) Global Historic Analysis in US$
Million by Region/Country: 2012-2019
Table 18: Hospitals (End-Use) Distribution of Global Sales by
Region/Country: 2012 VS 2020 VS 2027
Table 19: Clinical Laboratories (End-Use) Sales Estimates and
Forecasts in US$ Million by Region/Country for the Years 2020
through 2027
Table 20: Clinical Laboratories (End-Use) Analysis of Historic
Sales in US$ Million by Region/Country for the Years 2012 to
2019
Table 21: Clinical Laboratories (End-Use) Global Market Share
Distribution by Region/Country for 2012, 2020, and 2027
Table 22: Physician Offices (End-Use) Global Opportunity
Assessment in US$ Million by Region/Country: 2020-2027
Table 23: Physician Offices (End-Use) Historic Sales Analysis
in US$ Million by Region/Country: 2012-2019
Table 24: Physician Offices (End-Use) Percentage Share
Breakdown of Global Sales by Region/Country: 2012 VS 2020 VS
2027
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Respiratory Disease Testing Market Share (in %) by Company:
2019 & 2025
Market Analytics
Table 25: United States Respiratory Disease Testing Market
Estimates and Projections in US$ Million by Test Type: 2020 to
2027
Table 26: Respiratory Disease Testing Market in the United
States by Test Type: A Historic Review in US$ Million for
2012-2019
Table 27: United States Respiratory Disease Testing Market
Share Breakdown by Test Type: 2012 VS 2020 VS 2027
Table 28: United States Respiratory Disease Testing Latent
Demand Forecasts in US$ Million by End-Use: 2020 to 2027
Table 29: Respiratory Disease Testing Historic Demand Patterns
in the United States by End-Use in US$ Million for 2012-2019
Table 30: Respiratory Disease Testing Market Share Breakdown in
the United States by End-Use: 2012 VS 2020 VS 2027
CANADA
Table 31: Canadian Respiratory Disease Testing Market Estimates
and Forecasts in US$ Million by Test Type: 2020 to 2027
Table 32: Canadian Respiratory Disease Testing Historic Market
Review by Test Type in US$ Million: 2012-2019
Table 33: Respiratory Disease Testing Market in Canada:
Percentage Share Breakdown of Sales by Test Type for 2012,
2020, and 2027
Table 34: Canadian Respiratory Disease Testing Market
Quantitative Demand Analysis in US$ Million by End-Use: 2020 to
2027
Table 35: Respiratory Disease Testing Market in Canada:
Summarization of Historic Demand Patterns in US$ Million by
End-Use for 2012-2019
Table 36: Canadian Respiratory Disease Testing Market Share
Analysis by End-Use: 2012 VS 2020 VS 2027
JAPAN
Table 37: Japanese Market for Respiratory Disease Testing:
Annual Sales Estimates and Projections in US$ Million by Test
Type for the Period 2020-2027
Table 38: Respiratory Disease Testing Market in Japan: Historic
Sales Analysis in US$ Million by Test Type for the Period
2012-2019
Table 39: Japanese Respiratory Disease Testing Market Share
Analysis by Test Type: 2012 VS 2020 VS 2027
Table 40: Japanese Demand Estimates and Forecasts for
Respiratory Disease Testing in US$ Million by End-Use: 2020 to
2027
Table 41: Japanese Respiratory Disease Testing Market in US$
Million by End-Use: 2012-2019
Table 42: Respiratory Disease Testing Market Share Shift in
Japan by End-Use: 2012 VS 2020 VS 2027
CHINA
Table 43: Chinese Respiratory Disease Testing Market Growth
Prospects in US$ Million by Test Type for the Period 2020-2027
Table 44: Respiratory Disease Testing Historic Market Analysis
in China in US$ Million by Test Type: 2012-2019
Table 45: Chinese Respiratory Disease Testing Market by Test
Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
Table 46: Chinese Demand for Respiratory Disease Testing in US$
Million by End-Use: 2020 to 2027
Table 47: Respiratory Disease Testing Market Review in China in
US$ Million by End-Use: 2012-2019
Table 48: Chinese Respiratory Disease Testing Market Share
Breakdown by End-Use: 2012 VS 2020 VS 2027
EUROPE
Market Facts & Figures
European Respiratory Disease Testing Market: Competitor Market
Share Scenario (in %) for 2019 & 2025
Market Analytics
Table 49: European Respiratory Disease Testing Market Demand
Scenario in US$ Million by Region/Country: 2020-2027
Table 50: Respiratory Disease Testing Market in Europe:
A Historic Market Perspective in US$ Million by Region/Country
for the Period 2012-2019
Table 51: European Respiratory Disease Testing Market Share
Shift by Region/Country: 2012 VS 2020 VS 2027
Table 52: European Respiratory Disease Testing Market Estimates
and Forecasts in US$ Million by Test Type: 2020-2027
Table 53: Respiratory Disease Testing Market in Europe in US$
Million by Test Type: A Historic Review for the Period
2012-2019
Table 54: European Respiratory Disease Testing Market Share
Breakdown by Test Type: 2012 VS 2020 VS 2027
Table 55: European Respiratory Disease Testing Addressable
Market Opportunity in US$ Million by End-Use: 2020-2027
Table 56: Respiratory Disease Testing Market in Europe:
Summarization of Historic Demand in US$ Million by End-Use for
the Period 2012-2019
Table 57: European Respiratory Disease Testing Market Share
Analysis by End-Use: 2012 VS 2020 VS 2027
FRANCE
Table 58: Respiratory Disease Testing Market in France by Test
Type: Estimates and Projections in US$ Million for the Period
2020-2027
Table 59: French Respiratory Disease Testing Historic Market
Scenario in US$ Million by Test Type: 2012-2019
Table 60: French Respiratory Disease Testing Market Share
Analysis by Test Type: 2012 VS 2020 VS 2027
Table 61: Respiratory Disease Testing Quantitative Demand
Analysis in France in US$ Million by End-Use: 2020-2027
Table 62: French Respiratory Disease Testing Historic Market
Review in US$ Million by End-Use: 2012-2019
Table 63: French Respiratory Disease Testing Market Share
Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and
2027
GERMANY
Table 64: Respiratory Disease Testing Market in Germany: Recent
Past, Current and Future Analysis in US$ Million by Test Type
for the Period 2020-2027
Table 65: German Respiratory Disease Testing Historic Market
Analysis in US$ Million by Test Type: 2012-2019
Table 66: German Respiratory Disease Testing Market Share
Breakdown by Test Type: 2012 VS 2020 VS 2027
Table 67: Respiratory Disease Testing Market in Germany: Annual
Sales Estimates and Forecasts in US$ Million by End-Use for the
Period 2020-2027
Table 68: German Respiratory Disease Testing Market in
Retrospect in US$ Million by End-Use: 2012-2019
Table 69: Respiratory Disease Testing Market Share Distribution
in Germany by End-Use: 2012 VS 2020 VS 2027
ITALY
Table 70: Italian Respiratory Disease Testing Market Growth
Prospects in US$ Million by Test Type for the Period 2020-2027
Table 71: Respiratory Disease Testing Historic Market Analysis
in Italy in US$ Million by Test Type: 2012-2019
Table 72: Italian Respiratory Disease Testing Market by Test
Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
Table 73: Italian Demand for Respiratory Disease Testing in US$
Million by End-Use: 2020 to 2027
Table 74: Respiratory Disease Testing Market Review in Italy in
US$ Million by End-Use: 2012-2019
Table 75: Italian Respiratory Disease Testing Market Share
Breakdown by End-Use: 2012 VS 2020 VS 2027
UNITED KINGDOM
Table 76: United Kingdom Market for Respiratory Disease
Testing: Annual Sales Estimates and Projections in US$ Million
by Test Type for the Period 2020-2027
Table 77: Respiratory Disease Testing Market in the United
Kingdom: Historic Sales Analysis in US$ Million by Test Type
for the Period 2012-2019
Table 78: United Kingdom Respiratory Disease Testing Market
Share Analysis by Test Type: 2012 VS 2020 VS 2027
Table 79: United Kingdom Demand Estimates and Forecasts for
Respiratory Disease Testing in US$ Million by End-Use: 2020 to
2027
Table 80: United Kingdom Respiratory Disease Testing Market in
US$ Million by End-Use: 2012-2019
Table 81: Respiratory Disease Testing Market Share Shift in the
United Kingdom by End-Use: 2012 VS 2020 VS 2027
SPAIN
Table 82: Spanish Respiratory Disease Testing Market Estimates
and Forecasts in US$ Million by Test Type: 2020 to 2027
Table 83: Spanish Respiratory Disease Testing Historic Market
Review by Test Type in US$ Million: 2012-2019
Table 84: Respiratory Disease Testing Market in Spain:
Percentage Share Breakdown of Sales by Test Type for 2012,
2020, and 2027
Table 85: Spanish Respiratory Disease Testing Market
Quantitative Demand Analysis in US$ Million by End-Use: 2020 to
2027
Table 86: Respiratory Disease Testing Market in Spain:
Summarization of Historic Demand Patterns in US$ Million by
End-Use for 2012-2019
Table 87: Spanish Respiratory Disease Testing Market Share
Analysis by End-Use: 2012 VS 2020 VS 2027
RUSSIA
Table 88: Russian Respiratory Disease Testing Market Estimates
and Projections in US$ Million by Test Type: 2020 to 2027
Table 89: Respiratory Disease Testing Market in Russia by Test
Type: A Historic Review in US$ Million for 2012-2019
Table 90: Russian Respiratory Disease Testing Market Share
Breakdown by Test Type: 2012 VS 2020 VS 2027
Table 91: Russian Respiratory Disease Testing Latent Demand
Forecasts in US$ Million by End-Use: 2020 to 2027
Table 92: Respiratory Disease Testing Historic Demand Patterns
in Russia by End-Use in US$ Million for 2012-2019
Table 93: Respiratory Disease Testing Market Share Breakdown in
Russia by End-Use: 2012 VS 2020 VS 2027
REST OF EUROPE
Table 94: Rest of Europe Respiratory Disease Testing Market
Estimates and Forecasts in US$ Million by Test Type: 2020-2027
Table 95: Respiratory Disease Testing Market in Rest of Europe
in US$ Million by Test Type: A Historic Review for the Period
2012-2019
Table 96: Rest of Europe Respiratory Disease Testing Market
Share Breakdown by Test Type: 2012 VS 2020 VS 2027
Table 97: Rest of Europe Respiratory Disease Testing
Addressable Market Opportunity in US$ Million by End-Use:
2020-2027
Table 98: Respiratory Disease Testing Market in Rest of Europe:
Summarization of Historic Demand in US$ Million by End-Use for
the Period 2012-2019
Table 99: Rest of Europe Respiratory Disease Testing Market
Share Analysis by End-Use: 2012 VS 2020 VS 2027
ASIA-PACIFIC
Table 100: Asia-Pacific Respiratory Disease Testing Market
Estimates and Forecasts in US$ Million by Region/Country:
2020-2027
Table 101: Respiratory Disease Testing Market in Asia-Pacific:
Historic Market Analysis in US$ Million by Region/Country for
the Period 2012-2019
Table 102: Asia-Pacific Respiratory Disease Testing Market
Share Analysis by Region/Country: 2012 VS 2020 VS 2027
Table 103: Respiratory Disease Testing Market in Asia-Pacific
by Test Type: Estimates and Projections in US$ Million for the
Period 2020-2027
Table 104: Asia-Pacific Respiratory Disease Testing Historic
Market Scenario in US$ Million by Test Type: 2012-2019
Table 105: Asia-Pacific Respiratory Disease Testing Market
Share Analysis by Test Type: 2012 VS 2020 VS 2027
Table 106: Respiratory Disease Testing Quantitative Demand
Analysis in Asia-Pacific in US$ Million by End-Use: 2020-2027
Table 107: Asia-Pacific Respiratory Disease Testing Historic
Market Review in US$ Million by End-Use: 2012-2019
Table 108: Asia-Pacific Respiratory Disease Testing Market
Share Analysis: A 17-Year Perspectiveby End-Use for 2012, 2020,
and 2027
AUSTRALIA
Table 109: Respiratory Disease Testing Market in Australia:
Recent Past, Current and Future Analysis in US$ Million by Test
Type for the Period 2020-2027
Table 110: Australian Respiratory Disease Testing Historic
Market Analysis in US$ Million by Test Type: 2012-2019
Table 111: Australian Respiratory Disease Testing Market Share
Breakdown by Test Type: 2012 VS 2020 VS 2027
Table 112: Respiratory Disease Testing Market in Australia:
Annual Sales Estimates and Forecasts in US$ Million by End-Use
for the Period 2020-2027
Table 113: Australian Respiratory Disease Testing Market in
Retrospect in US$ Million by End-Use: 2012-2019
Table 114: Respiratory Disease Testing Market Share
Distribution in Australia by End-Use: 2012 VS 2020 VS 2027
INDIA
Table 115: Indian Respiratory Disease Testing Market Estimates
and Forecasts in US$ Million by Test Type: 2020 to 2027
Table 116: Indian Respiratory Disease Testing Historic Market
Review by Test Type in US$ Million: 2012-2019
Table 117: Respiratory Disease Testing Market in India:
Percentage Share Breakdown of Sales by Test Type for 2012,
2020, and 2027
Table 118: Indian Respiratory Disease Testing Market
Quantitative Demand Analysis in US$ Million by End-Use: 2020 to
2027
Table 119: Respiratory Disease Testing Market in India:
Summarization of Historic Demand Patterns in US$ Million by
End-Use for 2012-2019
Table 120: Indian Respiratory Disease Testing Market Share
Analysis by End-Use: 2012 VS 2020 VS 2027
SOUTH KOREA
Table 121: Respiratory Disease Testing Market in South Korea:
Recent Past, Current and Future Analysis in US$ Million by Test
Type for the Period 2020-2027
Table 122: South Korean Respiratory Disease Testing Historic
Market Analysis in US$ Million by Test Type: 2012-2019
Table 123: Respiratory Disease Testing Market Share
Distribution in South Korea by Test Type: 2012 VS 2020 VS 2027
Table 124: Respiratory Disease Testing Market in South Korea:
Recent Past, Current and Future Analysis in US$ Million by
End-Use for the Period 2020-2027
Table 125: South Korean Respiratory Disease Testing Historic
Market Analysis in US$ Million by End-Use: 2012-2019
Table 126: Respiratory Disease Testing Market Share
Distribution in South Korea by End-Use: 2012 VS 2020 VS 2027
REST OF ASIA-PACIFIC
Table 127: Rest of Asia-Pacific Market for Respiratory Disease
Testing: Annual Sales Estimates and Projections in US$ Million
by Test Type for the Period 2020-2027
Table 128: Respiratory Disease Testing Market in Rest of
Asia-Pacific: Historic Sales Analysis in US$ Million by Test
Type for the Period 2012-2019
Table 129: Rest of Asia-Pacific Respiratory Disease Testing
Market Share Analysis by Test Type: 2012 VS 2020 VS 2027
Table 130: Rest of Asia-Pacific Demand Estimates and Forecasts
for Respiratory Disease Testing in US$ Million by End-Use: 2020
to 2027
Table 131: Rest of Asia-Pacific Respiratory Disease Testing
Market in US$ Million by End-Use: 2012-2019
Table 132: Respiratory Disease Testing Market Share Shift in
Rest of Asia-Pacific by End-Use: 2012 VS 2020 VS 2027
LATIN AMERICA
Table 133: Latin American Respiratory Disease Testing Market
Trends by Region/Country in US$ Million: 2020-2027
Table 134: Respiratory Disease Testing Market in Latin America
in US$ Million by Region/Country: A Historic Perspective for
the Period 2012-2019
Table 135: Latin American Respiratory Disease Testing Market
Percentage Breakdown of Sales by Region/Country: 2012, 2020,
and 2027
Table 136: Latin American Respiratory Disease Testing Market
Growth Prospects in US$ Million by Test Type for the Period
2020-2027
Table 137: Respiratory Disease Testing Historic Market Analysis
in Latin America in US$ Million by Test Type: 2012-2019
Table 138: Latin American Respiratory Disease Testing Marketby
Test Type: Percentage Breakdown of Sales for 2012, 2020, and
2027
Table 139: Latin American Demand for Respiratory Disease
Testing in US$ Million by End-Use: 2020 to 2027
Table 140: Respiratory Disease Testing Market Review in Latin
America in US$ Million by End-Use: 2012-2019
Table 141: Latin American Respiratory Disease Testing Market
Share Breakdown by End-Use: 2012 VS 2020 VS 2027
ARGENTINA
Table 142: Argentinean Respiratory Disease Testing Market
Estimates and Forecasts in US$ Million by Test Type: 2020-2027
Table 143: Respiratory Disease Testing Market in Argentina in
US$ Million by Test Type: A Historic Review for the Period
2012-2019
Table 144: Argentinean Respiratory Disease Testing Market Share
Breakdown by Test Type: 2012 VS 2020 VS 2027
Table 145: Argentinean Respiratory Disease Testing Addressable
Market Opportunity in US$ Million by End-Use: 2020-2027
Table 146: Respiratory Disease Testing Market in Argentina:
Summarization of Historic Demand in US$ Million by End-Use for
the Period 2012-2019
Table 147: Argentinean Respiratory Disease Testing Market Share
Analysis by End-Use: 2012 VS 2020 VS 2027
BRAZIL
Table 148: Respiratory Disease Testing Market in Brazil by Test
Type: Estimates and Projections in US$ Million for the Period
2020-2027
Table 149: Brazilian Respiratory Disease Testing Historic
Market Scenario in US$ Million by Test Type: 2012-2019
Table 150: Brazilian Respiratory Disease Testing Market Share
Analysis by Test Type: 2012 VS 2020 VS 2027
Table 151: Respiratory Disease Testing Quantitative Demand
Analysis in Brazil in US$ Million by End-Use: 2020-2027
Table 152: Brazilian Respiratory Disease Testing Historic
Market Review in US$ Million by End-Use: 2012-2019
Table 153: Brazilian Respiratory Disease Testing Market Share
Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and
2027
MEXICO
Table 154: Respiratory Disease Testing Market in Mexico: Recent
Past, Current and Future Analysis in US$ Million by Test Type
for the Period 2020-2027
Table 155: Mexican Respiratory Disease Testing Historic Market
Analysis in US$ Million by Test Type: 2012-2019
Table 156: Mexican Respiratory Disease Testing Market Share
Breakdown by Test Type: 2012 VS 2020 VS 2027
Table 157: Respiratory Disease Testing Market in Mexico: Annual
Sales Estimates and Forecasts in US$ Million by End-Use for the
Period 2020-2027
Table 158: Mexican Respiratory Disease Testing Market in
Retrospect in US$ Million by End-Use: 2012-2019
Table 159: Respiratory Disease Testing Market Share
Distribution in Mexico by End-Use: 2012 VS 2020 VS 2027
REST OF LATIN AMERICA
Table 160: Rest of Latin America Respiratory Disease Testing
Market Estimates and Projections in US$ Million by Test Type:
2020 to 2027
Table 161: Respiratory Disease Testing Market in Rest of Latin
America by Test Type: A Historic Review in US$ Million for
2012-2019
Table 162: Rest of Latin America Respiratory Disease Testing
Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027
Table 163: Rest of Latin America Respiratory Disease Testing
Latent Demand Forecasts in US$ Million by End-Use: 2020 to 2027
Table 164: Respiratory Disease Testing Historic Demand Patterns
in Rest of Latin America by End-Use in US$ Million for
2012-2019
Table 165: Respiratory Disease Testing Market Share Breakdown
in Rest of Latin America by End-Use: 2012 VS 2020 VS 2027
MIDDLE EAST
Table 166: The Middle East Respiratory Disease Testing Market
Estimates and Forecasts in US$ Million by Region/Country:
2020-2027
Table 167: Respiratory Disease Testing Market in the Middle
East by Region/Country in US$ Million: 2012-2019
Table 168: The Middle East Respiratory Disease Testing Market
Share Breakdown by Region/Country: 2012, 2020, and 2027
Table 169: The Middle East Respiratory Disease Testing Market
Estimates and Forecasts in US$ Million by Test Type: 2020 to
2027
Table 170: The Middle East Respiratory Disease Testing Historic
Marketby Test Type in US$ Million: 2012-2019
Table 171: Respiratory Disease Testing Market in the Middle
East: Percentage Share Breakdown of Salesby Test Type for
2012,2020, and 2027
Table 172: The Middle East Respiratory Disease Testing Market
Quantitative Demand Analysis in US$ Million by End-Use: 2020 to
2027
Table 173: Respiratory Disease Testing Market in the Middle
East: Summarization of Historic Demand Patterns in US$ Million
by End-Use for 2012-2019
Table 174: The Middle East Respiratory Disease Testing Market
Share Analysis by End-Use: 2012 VS 2020 VS 2027
IRAN
Table 175: Iranian Market for Respiratory Disease Testing:
Annual Sales Estimates and Projections in US$ Million by Test
Type for the Period 2020-2027
Table 176: Respiratory Disease Testing Market in Iran: Historic
Sales Analysis in US$ Million by Test Type for the Period
2012-2019
Table 177: Iranian Respiratory Disease Testing Market Share
Analysis by Test Type: 2012 VS 2020 VS 2027
Table 178: Iranian Demand Estimates and Forecasts for
Respiratory Disease Testing in US$ Million by End-Use: 2020 to
2027
Table 179: Iranian Respiratory Disease Testing Market in US$
Million by End-Use: 2012-2019
Table 180: Respiratory Disease Testing Market Share Shift in
Iran by End-Use: 2012 VS 2020 VS 2027
ISRAEL
Table 181: Israeli Respiratory Disease Testing Market Estimates
and Forecasts in US$ Million by Test Type: 2020-2027
Table 182: Respiratory Disease Testing Market in Israel in US$
Million by Test Type: A Historic Review for the Period
2012-2019
Table 183: Israeli Respiratory Disease Testing Market Share
Breakdown by Test Type: 2012 VS 2020 VS 2027
Table 184: Israeli Respiratory Disease Testing Addressable
Market Opportunity in US$ Million by End-Use: 2020-2027
Table 185: Respiratory Disease Testing Market in Israel:
Summarization of Historic Demand in US$ Million by End-Use for
the Period 2012-2019
Table 186: Israeli Respiratory Disease Testing Market Share
Analysis by End-Use: 2012 VS 2020 VS 2027
SAUDI ARABIA
Table 187: Saudi Arabian Respiratory Disease Testing Market
Growth Prospects in US$ Million by Test Type for the Period
2020-2027
Table 188: Respiratory Disease Testing Historic Market Analysis
in Saudi Arabia in US$ Million by Test Type: 2012-2019
Table 189: Saudi Arabian Respiratory Disease Testing Market by
Test Type: Percentage Breakdown of Sales for 2012, 2020, and
2027
Table 190: Saudi Arabian Demand for Respiratory Disease Testing
in US$ Million by End-Use: 2020 to 2027
Table 191: Respiratory Disease Testing Market Review in Saudi
Arabia in US$ Million by End-Use: 2012-2019
Table 192: Saudi Arabian Respiratory Disease Testing Market
Share Breakdown by End-Use: 2012 VS 2020 VS 2027
UNITED ARAB EMIRATES
Table 193: Respiratory Disease Testing Market in the United
Arab Emirates: Recent Past, Current and Future Analysis in US$
Million by Test Type for the Period 2020-2027
Table 194: United Arab Emirates Respiratory Disease Testing
Historic Market Analysis in US$ Million by Test Type: 2012-2019
Table 195: Respiratory Disease Testing Market Share
Distribution in United Arab Emirates by Test Type: 2012 VS 2020
VS 2027
Table 196: Respiratory Disease Testing Market in the United
Arab Emirates: Recent Past, Current and Future Analysis in US$
Million by End-Use for the Period 2020-2027
Table 197: United Arab Emirates Respiratory Disease Testing
Historic Market Analysis in US$ Million by End-Use: 2012-2019
Table 198: Respiratory Disease Testing Market Share
Distribution in United Arab Emirates by End-Use: 2012 VS 2020
VS 2027
REST OF MIDDLE EAST
Table 199: Respiratory Disease Testing Market in Rest of Middle
East: Recent Past, Current and Future Analysis in US$ Million
by Test Type for the Period 2020-2027
Table 200: Rest of Middle East Respiratory Disease Testing
Historic Market Analysis in US$ Million by Test Type: 2012-2019
Table 201: Rest of Middle East Respiratory Disease Testing
Market Share Breakdown by Test Type: 2012 VS 2020 VS 2027
Table 202: Respiratory Disease Testing Market in Rest of Middle
East: Annual Sales Estimates and Forecasts in US$ Million by
End-Use for the Period 2020-2027
Table 203: Rest of Middle East Respiratory Disease Testing
Market in Retrospect in US$ Million by End-Use: 2012-2019
Table 204: Respiratory Disease Testing Market Share
Distribution in Rest of Middle East by End-Use: 2012 VS 2020 VS
2027
AFRICA
Table 205: African Respiratory Disease Testing Market Estimates
and Projections in US$ Million by Test Type: 2020 to 2027
Table 206: Respiratory Disease Testing Market in Africa by Test
Type: A Historic Review in US$ Million for 2012-2019
Table 207: African Respiratory Disease Testing Market Share
Breakdown by Test Type: 2012 VS 2020 VS 2027
Table 208: African Respiratory Disease Testing Latent Demand
Forecasts in US$ Million by End-Use: 2020 to 2027
Table 209: Respiratory Disease Testing Historic Demand Patterns
in Africa by End-Use in US$ Million for 2012-2019
Table 210: Respiratory Disease Testing Market Share Breakdown
in Africa by End-Use: 2012 VS 2020 VS 2027
IV. COMPETITION
Total Companies Profiled: 43
Read the full report: https://www.reportlinker.com/p05959891/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001
ReportLinker
Lyon, FRANCE
ReportLinker logo.jpg
Formats available: